To add to the controversy, a retrospective survey from the US conducted on 120 military persons diagnosed with MS found that serum NfL levels of these individuals were elevated years before diagnosis, and a within-person increase was associated with a shorter time to clinical onset [300]. The gene discussed is NEFL; the disease is myeloid sarcoma.